| scholarly article | Q13442814 |
| P50 | author | David Mörtsell | Q80183410 |
| P2093 | author name string | Carina Blomström-Lundqvist | |
| Lennart Bergfeldt | |||
| Sigfus Gizurarson | |||
| Steen M Jensen | |||
| Pekka Raatikainen | |||
| Helena Malmborg | |||
| Jonas Schwieler | |||
| Stefan Lönnerholm | |||
| Göran Kennebäck | |||
| Aigars Rubulis | |||
| Niklas Höglund | |||
| P2860 | cites work | Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? | Q80456389 |
| Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study) | Q81330735 | ||
| Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation | Q82220284 | ||
| Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? | Q83978153 | ||
| Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation | Q85262354 | ||
| Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial | Q86410104 | ||
| 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. | Q34538645 | ||
| The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden | Q36790923 | ||
| Asymptomatic atrial fibrillation on device interrogation | Q37163472 | ||
| Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation | Q37278794 | ||
| Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). | Q37595974 | ||
| Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial | Q38376136 | ||
| Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. | Q38418101 | ||
| Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial | Q38435943 | ||
| Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial | Q39919773 | ||
| Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life | Q43695551 | ||
| Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study | Q43984938 | ||
| 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation | Q45059153 | ||
| Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy | Q45332649 | ||
| Circumferential pulmonary-vein ablation for chronic atrial fibrillation | Q46971003 | ||
| Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. | Q50780654 | ||
| Comparison of continuous versus intermittent monitoring of atrial arrhythmias. | Q50794198 | ||
| Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument. | Q50868122 | ||
| Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. | Q51433465 | ||
| Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. | Q51700664 | ||
| Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. | Q53295361 | ||
| Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. | Q53520330 | ||
| Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy | Q59248790 | ||
| A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study | Q79425842 | ||
| Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence | Q80357422 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| P304 | page(s) | 1059-1068 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial | |
| P478 | volume | 321 |
| Q90468109 | Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias |
| Q98578056 | Catheter Ablation vs. Medical Treatment in Patients With Atrial Fibrillation |
| Q100533956 | Catheter ablation for atrial fibrillation: current indications and evolving technologies |
| Q97570312 | Combined Therapy of Catheter Ablation and Left Atrial Appendage Closure for Patients with Atrial Fibrillation: A Case-Control Study |
| Q99406734 | Does Catheter Ablation Lower the Long-Term Risk of Stroke and Mortality in Patients with Atrial Fibrillation? A Concise Review of the Current State of Knowledge |
| Q99560133 | Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation |
| Q97646622 | Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysis |
| Q94595345 | Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure |
| Q90751047 | Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models |
| Q90107587 | Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5 |
| Q90723728 | Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications |
| Q97422268 | What Cannot Be Missed: Important Publications on Electrophysiology in 2019 |
Search more.